Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in

MLA

Christopher J M, Williams, et al. “Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit In.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 12, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........dcaec9959e1cdc2c93594b7dec3a6a81&authtype=sso&custid=ns315887.

APA

Christopher J M, W., Jenny F, S., Faye, E., Michael, S., Susan D, R., Sarah, B., Liping, Z., Shalini, S., Judith, P., Xiao-Meng, X., Andrea, M., Christoph, G., Auranuch, L., Uday, K., Zuo, Z., Jim, M., Xingwei, W., Kien, N., Wen-Wei, L., … Kandavel, S. (2021). Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(12).

Chicago

Christopher J M, Williams, Seligmann Jenny F, Elliott Faye, Shires Michael, Richman Susan D, Brown Sarah, Zhang Liping, et al. 2021. “Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit In.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........dcaec9959e1cdc2c93594b7dec3a6a81&authtype=sso&custid=ns315887.